Warburg Pincus

Warburg Pincus is a global private equity firm with a long-standing China presence, where it is known as 华平投资 (Huaping). It was among the first wave of international funds to establish offices in Beijing's Guomao CBD alongside peers such as KKR and Sequoia China . Unlike some competitors, it had not raised a dedicated RMB fund as of early 2022, though it was reported to be actively preparing one . The firm has pursued buyout-style transactions in China, including a notable 2021 add-on deal in which it facilitated Higea Healthcare's acquisition of Suzhou Yongding Hospital, later exiting at a return exceeding four times through the public markets . In late 2023, Warburg Pincus China underwent a leadership transition: Frank Wei (魏臻) stepped down as China president while remaining a managing director through 2024, with Fang Min and Zhou Lang appointed as co-heads of China private equity investing . The firm marked its thirtieth anniversary of China operations with a celebration in Shanghai in February 2024 .